+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dexamethasone Implant Market by Indication (Diabetic Macular Edema, Non-Infectious Posterior Uveitis, Retinal Vein Occlusion), End User (Ambulatory Surgery Centers, Hospitals, Ophthalmic Clinics), Distribution Channel, Strength - Global Forecast 2025-2030- Product Image
Dexamethasone Implant Market by Indication (Diabetic Macular Edema, Non-Infectious Posterior Uveitis, Retinal Vein Occlusion), End User (Ambulatory Surgery Centers, Hospitals, Ophthalmic Clinics), Distribution Channel, Strength - Global Forecast 2025-2030- Product Image
New

Dexamethasone Implant Market by Indication (Diabetic Macular Edema, Non-Infectious Posterior Uveitis, Retinal Vein Occlusion), End User (Ambulatory Surgery Centers, Hospitals, Ophthalmic Clinics), Distribution Channel, Strength - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6147177
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The growing burden of retinal diseases and the need for effective, sustained therapies have elevated the dexamethasone implant as a cornerstone in modern ophthalmic care. With its capacity to deliver corticosteroid medication over an extended period, this implant has reshaped treatment paradigms for conditions that traditionally required frequent intravitreal injections. Stakeholders across the healthcare continuum are now assessing how this innovation can improve patient compliance, enhance visual outcomes, and optimize resource utilization.

This executive summary is designed to provide senior leaders and clinical decision makers with a concise yet comprehensive overview of the dexamethasone implant landscape. By synthesizing key trends, market dynamics, regulatory shifts, and competitive activities, it illuminates both the opportunities and challenges that lie ahead. Readers will gain clear insight into the structural forces shaping the market, the implications of recent policy changes, and the strategic actions necessary to maintain a leadership position in this rapidly evolving segment.

Exploring the Fundamental Transformative Shifts Shaping the Dexamethasone Implant Market Landscape Through Technological, Regulatory, and Clinical Advancements

Advancements in drug delivery technology and formulation science have catalyzed a fundamental shift in ophthalmic therapeutics. The dexamethasone implant has capitalized on miniaturized sustained-release mechanisms and biocompatible polymer systems to extend dosing intervals and reduce patient burden. Enhanced precision in intravitreal injection devices, coupled with refined implant compositions, has contributed to improved safety profiles and heightened physician confidence.

Simultaneously, regulatory bodies have refined guidelines for intraocular corticosteroid implants, demanding rigorous clinical evidence and post-market surveillance. These evolving standards have encouraged manufacturers to invest in robust safety and efficacy studies, while payers increasingly demand real-world data to support reimbursement decisions. The convergence of clinical innovation and regulatory rigor is redefining treatment pathways and compelling all stakeholders to adapt to a more evidence-driven environment.

Assessing the Comprehensive Implications of United States Tariff Adjustments in 2025 on Supply Chains, Manufacturing Costs, and Adoption Dynamics for Dexamethasone Implants

The implementation of new U.S. tariffs in 2025 has introduced notable pressure on the importation of key components required for dexamethasone implant production. Manufacturers have responded by reassessing global sourcing strategies and exploring domestic supply alternatives to mitigate heightened input costs. These adjustments have prompted a recalibration of pricing frameworks, with companies seeking to balance profitability against the imperative of maintaining patient access.

Moreover, distributors and healthcare providers have had to adapt their procurement models to manage the impact of increased import expenses. Some organizations have negotiated volume-based contracts or shifted to alternative distribution channels to preserve cost efficiencies. As reimbursement policies evolve in parallel, stakeholders must navigate a complex interplay of tariff-driven cost increases and payer expectations to sustain market momentum.

Deriving Critical Insights from Segmentation Analysis by Indication, End User, Distribution Channel, and Strength to Guide Strategic Positioning in the Dexamethasone Implant Market

Analysis by indication reveals that diabetic macular edema continues to dominate clinical utilization, with both diffuse macular edema and focal macular edema subcategories driving significant therapeutic demand. Non-infectious posterior uveitis specialists are focusing on intermediate uveitis and panuveitis cases where sustained corticosteroid delivery addresses chronic inflammation with fewer intervention cycles. Retinal vein occlusion remains a key area of interest, particularly in branch retinal vein occlusion and central retinal vein occlusion cohorts where implant efficacy has been demonstrated in vision stabilization.

When examining end users, ambulatory surgery centers have emerged as critical settings in both hospital-affiliated facilities and independent centers, reflecting a trend toward outpatient treatment models. Hospital systems-encompassing government and private institutions-continue to integrate implant procedures within broader ophthalmology service lines, while ophthalmic clinics, including multi-specialty eye centers and single-specialty practices, are expanding capacity to meet rising patient volumes. Distribution channel dynamics further underscore the importance of hospital pharmacies across inpatient and outpatient contexts, the growing role of e-commerce platforms in online pharmacies, and the sustained relevance of retail outlets through chain and independent pharmacies. Finally, the core product offering in both 0.7 mg and 1.4 mg strengths ensures clinicians can tailor therapy to disease severity and patient needs.

Unveiling Key Regional Dynamics Across Americas, Europe Middle East & Africa, and Asia Pacific to Highlight Growth Drivers and Adoption Patterns for Dexamethasone Implants

Regionally, the Americas lead in the adoption of dexamethasone implants, driven by high healthcare expenditure, well-established reimbursement frameworks, and robust clinical infrastructure. North American centers of excellence and specialized retina practices have accelerated uptake, positioning the region at the forefront of best practice implementation. Market participants here benefit from integrated care models and transparent regulatory pathways that facilitate timely product launches.

In Europe, the Middle East & Africa, heterogeneous reimbursement systems and variable regulatory timelines create a complex environment. While Western European nations display strong implant penetration, emerging healthcare markets in Eastern Europe, the Gulf region, and parts of Africa present both challenges and growth potential. Asia Pacific illustrates rapid expansion, underpinned by increasing retinal disease prevalence, strategic infrastructure investments, and growing private sector involvement. Variations in policy support and provider capacity across Asia Pacific markets will shape differentiated adoption trajectories.

Highlighting Strategic Movements and Competitive Positioning of Leading Companies Shaping Innovation, Collaborations, and Market Penetration in the Dexamethasone Implant Space

Leading companies in the dexamethasone implant space are actively strengthening their portfolios through targeted research collaborations and strategic licensing agreements. These partnerships often align with specialty pharmaceutical firms and academic institutions to accelerate formulation enhancements and expand indications. Concurrently, established pharmaceutical manufacturers are investing in manufacturing scale-up to secure supply continuity and meet rising demand in key geographies.

Competitive positioning also reflects ongoing efforts to optimize patient support programs and bolster health economics outcomes. Manufacturers are engaging with payers and providers to generate real-world evidence supporting long-term cost-effectiveness. Additionally, several organizations are exploring next-generation delivery technologies and combination therapies to differentiate their product offerings and sustain market leadership.

Recommending Actionable Strategies for Industry Leaders to Enhance Market Access, Optimize Value Propositions, and Navigate Emerging Opportunities in Dexamethasone Implants

To seize emerging opportunities, industry leaders should explore adaptive pricing strategies that align with evolving reimbursement models and value-based contracting. Strengthening relationships with integrated delivery networks and specialty care centers can enhance market access and streamline patient pathways. Furthermore, forging alliances with domestic component suppliers and logistics providers will mitigate tariff-related cost pressures and reinforce supply chain resilience.

Continued investment in next-generation formulations and delivery systems will be critical to maintaining clinical differentiation. Innovators can also integrate digital health solutions to monitor patient adherence and outcomes in real time, thereby generating the evidence required for favorable formulary positioning. Proactive engagement with regulatory bodies and payer organizations will ensure that advocacy for data-driven value assessment remains front and center.

Outlining the Rigorous Research Methodology Combining Primary Interviews, Secondary Data Triangulation, and Analytical Frameworks Underpinning the Dexamethasone Implant Study

This study employed a multi-pronged research approach, combining in-depth interviews with key opinion leaders, industry executives, and clinical specialists to capture firsthand insights. Secondary research encompassed a thorough examination of peer-reviewed publications, clinical trial databases, regulatory filings, and publicly available financial statements to establish a robust evidentiary foundation.

Data were cross-validated through rigorous triangulation techniques, ensuring consistency and reliability. Analytical methodologies such as SWOT assessment, value chain analysis, and competitive benchmarking underpinned the evaluation of market dynamics and company strategies. Findings were iteratively reviewed with an expert advisory panel to refine conclusions and reinforce the study’s overall integrity.

Concluding Key Takeaways and Strategic Imperatives to Inform Decision Making and Future Directions in the Evolving Dexamethasone Implant Market Landscape

This executive summary has illuminated the key factors shaping the present and future trajectory of the dexamethasone implant market. Technological advancements and regulatory refinements are driving innovation in sustained-release therapies, while tariff changes necessitate strategic supply chain adjustments. Segmentation insights by indication, end user, distribution channel, and strength provide a clear framework for targeted market penetration, complemented by distinct regional growth patterns across the Americas, Europe Middle East & Africa, and Asia Pacific.

Competitive dynamics reflect robust investment in research collaborations, manufacturing expansion, and patient support initiatives. By adopting the recommended strategic imperatives-ranging from adaptive pricing and supply chain optimization to digital health integration and regulatory engagement-stakeholders can position themselves to achieve sustainable growth. The insights presented herein serve as a roadmap for informed decision making and decisive action in this vibrant and evolving therapeutic area.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Indication
    • Diabetic Macular Edema
      • Diffuse Macular Edema
      • Focal Macular Edema
    • Non-Infectious Posterior Uveitis
      • Intermediate Uveitis
      • Panuveitis
    • Retinal Vein Occlusion
      • Branch Retinal Vein Occlusion
      • Central Retinal Vein Occlusion
  • End User
    • Ambulatory Surgery Centers
      • Hospital-Affiliated Asc
      • Independent Asc
    • Hospitals
      • Government Hospitals
      • Private Hospitals
    • Ophthalmic Clinics
      • Multi-Specialty Eye Centers
      • Single-Specialty Clinics
  • Distribution Channel
    • Hospital Pharmacy
      • Inpatient Pharmacy
      • Outpatient Pharmacy
    • Online Pharmacy
      • E-Commerce Platforms
    • Retail Pharmacy
      • Chain Pharmacy
      • Independent Pharmacy
  • Strength
    • 0.7 Mg
    • 1.4 Mg
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • AbbVie Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals Ltd.
  • Lupin Limited
  • Cipla Limited
  • Alkem Laboratories Ltd.
  • Fresenius Kabi AG

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing off-label applications for dexamethasone implants in retinal vein occlusion management due to shifting clinical guidelines
5.2. Advances in biodegradable polymer technologies improving sustained-release profiles of dexamethasone intravitreal implants
5.3. Increasing adoption of dexamethasone implant in diabetic macular edema treatment driven by real-world evidence of efficacy
5.4. Rising investment in combination therapies integrating dexamethasone implants with anti-VEGF agents for synergistic retinal disease control
5.5. Competitive landscape shift as biosimilar dexamethasone implants enter key markets challenging established product exclusivity
5.6. Emergence of personalized dosing protocols for dexamethasone implants enabled by AI-based patient response monitoring platforms
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dexamethasone Implant Market, by Indication
8.1. Introduction
8.2. Diabetic Macular Edema
8.2.1. Diffuse Macular Edema
8.2.2. Focal Macular Edema
8.3. Non-Infectious Posterior Uveitis
8.3.1. Intermediate Uveitis
8.3.2. Panuveitis
8.4. Retinal Vein Occlusion
8.4.1. Branch Retinal Vein Occlusion
8.4.2. Central Retinal Vein Occlusion
9. Dexamethasone Implant Market, by End User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.2.1. Hospital-Affiliated Asc
9.2.2. Independent Asc
9.3. Hospitals
9.3.1. Government Hospitals
9.3.2. Private Hospitals
9.4. Ophthalmic Clinics
9.4.1. Multi-Specialty Eye Centers
9.4.2. Single-Specialty Clinics
10. Dexamethasone Implant Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.2.1. Inpatient Pharmacy
10.2.2. Outpatient Pharmacy
10.3. Online Pharmacy
10.3.1. E-Commerce Platforms
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Dexamethasone Implant Market, by Strength
11.1. Introduction
11.2. 0.7 Mg
11.3. 1.4 Mg
12. Americas Dexamethasone Implant Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Dexamethasone Implant Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Dexamethasone Implant Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AbbVie Inc.
15.3.2. Sandoz International GmbH
15.3.3. Teva Pharmaceutical Industries Ltd.
15.3.4. Viatris Inc.
15.3.5. Sun Pharmaceutical Industries Ltd.
15.3.6. Intas Pharmaceuticals Ltd.
15.3.7. Lupin Limited
15.3.8. Cipla Limited
15.3.9. Alkem Laboratories Ltd.
15.3.10. Fresenius Kabi AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DEXAMETHASONE IMPLANT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. DEXAMETHASONE IMPLANT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. DEXAMETHASONE IMPLANT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. DEXAMETHASONE IMPLANT MARKET: RESEARCHAI
FIGURE 24. DEXAMETHASONE IMPLANT MARKET: RESEARCHSTATISTICS
FIGURE 25. DEXAMETHASONE IMPLANT MARKET: RESEARCHCONTACTS
FIGURE 26. DEXAMETHASONE IMPLANT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DEXAMETHASONE IMPLANT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY DIFFUSE MACULAR EDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY DIFFUSE MACULAR EDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY FOCAL MACULAR EDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY FOCAL MACULAR EDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INTERMEDIATE UVEITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INTERMEDIATE UVEITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY PANUVEITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY PANUVEITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY BRANCH RETINAL VEIN OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY BRANCH RETINAL VEIN OCCLUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY CENTRAL RETINAL VEIN OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY CENTRAL RETINAL VEIN OCCLUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL-AFFILIATED ASC, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL-AFFILIATED ASC, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INDEPENDENT ASC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INDEPENDENT ASC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY MULTI-SPECIALTY EYE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY MULTI-SPECIALTY EYE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY SINGLE-SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY SINGLE-SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY 0.7 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY 0.7 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY 1.4 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DEXAMETHASONE IMPLANT MARKET SIZE, BY 1.4 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES DEXAMETHASONE IMPLANT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 150. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 151. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2018-2024 (USD MILLION)
TABLE 152. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2025-2030 (USD MILLION)
TABLE 153. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2024 (USD MILLION)
TABLE 154. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2025-2030 (USD MILLION)
TABLE 155. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 158. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 159. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2018-2024 (USD MILLION)
TABLE 162. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2025-2030 (USD MILLION)
TABLE 163. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 166. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 167. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 172. CANADA DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 173. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 176. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 177. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 194. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 195. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 196. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 197. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 198. MEXICO DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA DEXAMETHASONE IMPLANT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM DEXAMETHASONE IMPLANT MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 305. GERMANY DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 306. GERMANY DEXAMETHASONE IMPLANT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 307. GERMANY DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 308. GERMANY DEXAMETHASONE IMPLANT MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 309. GERMANY DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2018-2024 (USD MILLION)
TABLE 310. GERMANY DEXAMETHASONE IMPLANT MARKET SIZE, BY NON-INFECTIOUS POSTERIOR UVEITIS, 2025-2030 (USD MILLION)
TABLE 311. GERMANY DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2024 (USD MILLION)
TABLE 312. GERMANY DEXAMETHASONE IMPLANT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2025-2030 (USD MILLION)
TABLE 313. GERMANY DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. GERMANY DEXAMETHASONE IMPLANT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. GERMANY DEXAMETHASONE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTER

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Dexamethasone Implant market report include:
  • AbbVie Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals Ltd.
  • Lupin Limited
  • Cipla Limited
  • Alkem Laboratories Ltd.
  • Fresenius Kabi AG

Related Topics

Related Reports

Dexamethasone Sodium Phosphate Active Pharmaceutical Ingredients Market by Form (Injection, Ophthalmic Solution, Oral Suspension), Application (Anti-Allergic, Anti-Inflammatory, Dermatology), Dosage Strength, End User, Sales Channel - Global Forecast 2025-2030 - Product Image

Dexamethasone Sodium Phosphate Active Pharmaceutical Ingredients Market by Form (Injection, Ophthalmic Solution, Oral Suspension), Application (Anti-Allergic, Anti-Inflammatory, Dermatology), Dosage Strength, End User, Sales Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
India Dexamethasone Market, Competition, Forecast & Opportunities, 2019-2029 - Product Image

India Dexamethasone Market, Competition, Forecast & Opportunities, 2019-2029

  • Report
  • 71 Pages
  • India
From
Ocular Immunosuppressants Market by Product Type (Biologics, Calcineurin Inhibitors, Corticosteroids), Route of Administration (Injectable, Systemic, Topical), Indication, Form, Distribution Channel, Mechanism of Action - Global Forecast 2025-2030 - Product Image

Ocular Immunosuppressants Market by Product Type (Biologics, Calcineurin Inhibitors, Corticosteroids), Route of Administration (Injectable, Systemic, Topical), Indication, Form, Distribution Channel, Mechanism of Action - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Dexamethasone Acetate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Dexamethasone Acetate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 91 Pages
  • Global
From
Dexamethasone (CAS 50-02-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Dexamethasone (CAS 50-02-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.